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ALBERT B. SABIN * 
I have spent a great part of m y life in the pursuit of knowledge about 
the natural history of poliomyelitis and in the development of vaccines 
that may give m an the power to eliminate this disease as a source of 
human misery. On this occasion I have, therefore, chosen to present 
to you not a detailed analysis of isolated observations, which are already 
available for criticai evaluation in the scientific literature, but rather a 
review of some of the problems that had to be solved and m y interpre-
tation of the assembled facts which are the basis for the expectation 
that poliomyelitis may now be eliminated from many parts of the world. 
The following basic facts in the natural history of poliomyelitis are 
of fundamental importance in guiding our attempts completely to eli-
minate this disease: 
1. Poliomyelitis is primarily an infection of the human alimentary tract 
— and it is well to recall here that the crucial evidence for establi-
shing this fact became available only a little over 20 years ago. 
2. The polioviruses maintain themselves in nature by passing with con-
taminated feces, directly or indirectly from one susceptible human 
being to another. Except in unusual circumstances when people have 
paralysis of deglutition, the virus that is present in the posterior 
pharyngeal wall is swallowed and is not expelled through the mouth 
for transmission to others. While polioviruses are readily detected in 
extrahuman sites, such as flies and reaches which have access to 
human feces, there is no evidence at the present time, of a cycle 
of transmission independent of the human alimentary tract. 
3. There are only three main immunologically distinct types of polio-
virus and not an ever-changing, unmanageably larger number. This 
important fact, first established only about 12 years ago through the 
collaborative efforts of many investigators, has survived in the face 
of many extensive studies by more precise methods in the ensuing 
years. These later studies, however, did reveal the important fact 
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that some of the newly recognised Coxsackie and ECHO viruses may 
occasionally produce paralytic disease clinically indistinguishable 
from poliomyelitis. While the paralytic disease caused by these other 
enteric viruses fortunately occurs only rarely and is usually, but 
not always of short duration, it must, nevertheless, be expected to 
persist even after ali the disease caused by the three types of po-
liovirus has been eliminatecl by specific vaccination. 
4. Naturally acquired immunity can persist a lifetime in the absence 
of reinfection — a fact that has been established by the studies of 
Paul and his associates on Eskimos living in prolonged isolation from 
outside human contact. 
5. Natural infection leaves behind it varying degree of intestinal resis-
tance to viral multiplication, which serves to eliminate many people 
from the chain of transmission of the polioviruses. This important 
fact was established only during the past 10 years by two types of 
precise study: a) by observation of long duration on families prior 
to and following episodes of laboratory recognized natural infection, 
and b) by quantitative studies on excretion of virus after feecling 
oi various doses of attenuated strains. 
•6. Not ali naturally occuring polioviruses have the same capacity for 
multiplication in extraneural tissues outside the alimentary tract or 
the same capacity for damaging the neurones, whose destruction in 
large numbers is responsible for the paralysis. It was not until 
the important work of Enders, Weller and Robbins made it possible 
for us to recognise and measure the activity of polioviruses in cul-
tures of non-nervous tissue, that it became possible to learn so 
much about the properties of the polioviruses beyond their capacity 
for damaging the nervous system. These new methods also provided 
the tools for the selection of the special viral particles, from whose 
progeny it was possible to prepare the live, attenuated orally admi-
nistered poliovirus vaccines that now provide us with the means and 
the hope for the complete elimination of poliomyelitis. 
The development of an effective, formalinized virus vaccine by Dr. 
Salk provided the first means by which many thousands of cases of 
paralytic poliomyelitis could be prevented. Although killed virus vaccine 
of adequate potency and in an adequate number of doses can provide 
protection against paralysis for 90 per cent or more of vaccinated indi-
viduais, carefully controlled experimental and field studies have shown 
that it has no effect on the multiplication of polioviruses in the intes-
tinal tract of the immunized persons. Even the most extensive use of 
killed virus vaccine, that has been posible to achieve in some places, has 
not interfered with the continued dissemination of the naturally occur-
ring polioviruses, nor, when these viruses have been especially virulent, 
with the occurrence of serious epiclemics. Such epidemics have ocurred 
in the USA, Canada, Hungary, Israel, Japan most recently in Austrália. 
These epidemics affected the unvaccinated, the inadequately vaccinated, 
those wTho have failed to develop immunity even after three or more 
doses of killed virus vaccine, and those who had lost their immunity 
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a year or more after vaccination. There is no question that these epi-
demics would have claimed thousands more victims if it had not been 
for the beneficiai effects of the Salk vaccine among the large number 
w h o were adequately immunized with it. But the fact that those who 
are themselves adequately protected by the Salk vaccine, retain the ca-
pacity for disseminating dangerous polioviruses in their own families 
and communities is one of the most important factors in the continued 
occurrence of poliomyelitis among highly vaccinated populations. 
Our present knowledge of the properties and behavior of the live, 
attenuated poliovirus vaccines has been laboriously accumulated during 
the past ten years by the studies of large numbers of investigators in 
many parts of the world. I hope you will forgive m e if at this point I 
reminisce a little about some of the major steps and problems in the 
development of the attenuated, oral poliovirus vaccines currently in use 
in almost every part of the world. At first there was the task of fin-
ding by experimental modification and selection of strains of poliovirus 
of each of the three types that had the least residual activity in the 
nervous system, the least capacity for multiplication in extraneural tis-
sues outside of the alimentary tract as measured by viremia, and the 
greatest capacity for multiplication in the intestinal tract. Quantitative 
studies on monkeys and chimpanzees established that the nervous system 
of the lower primates, were more susceptible to poliovirus than that of 
the higher primates, while the reverse was true for the alimentary tract. 
Thus, it became necessary to extend the studies to human volunteers 
when it was found that polioviruses that were devoid of paralytogenic 
activity in chimpanzees multiplied poorly or not at ali in the alimen-
tary tract of monkeys, and that amounts of virus that multiplied 
poorly or not at ali in the alimentary tract of chimpanzees, multiplied 
very well in the intestinal tract of susceptible adult human volunteers. 
The paralytogenic activity of highly virulent polioviruses when given by 
mouth to chimpanzees, compared with the incidence of paralysis in human 
beings during the course of the most severe epidemics on record, was 
the basis for the assumption that the nervous system of the most highly 
susceptible human beings was no more susceptible to polioviruses than 
that of chimpanzees. Thus each strain that was completely avirulent by 
direct intraspinal inoculation of very large doses in chimpanzees, was 
then studied for its behavior on feeding to nonimmune adult volunteers. 
The strains that were finally selected had the least residual activity in 
the spinal cord of the more susceptible monkeys, and multiplied in the 
intestinal tract of the human volunteers, with little or no demonstrable 
viremia, and with the least detectable alteration in neurovirulence of the 
virus excreted in the stools. The appearance in the stools of some virus 
particles, that were less attenuated than the virus that was fed as de-
termined by direct inoculation of different amounts of virus in the ner-
vous system of monkeys, was the subject of many extensive studies. 
With the more desirable strains these altered virus particles appeared 
rather late during multiplication in the intestinal tract after the indi-
vidual had already developed specific antibodies. These altered particles, 
did not have a selective advantage in the intestinal tract, since they 
often disappeared after continued multiplication, and did not significan-
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tly increase in amount or virulence on continued transmission from one 
person to another. Although it at first seemed that this phenomenon 
might be due to the fact that the virus that was fed consisted of a 
genetically mixed population of virus particles, it was found that the 
progeny of multiply purified single plaques behaved in a similar manner 
after multiplication in human intestinal tract. Beginning in 1957, exten-
sive studies were carried out with the selected strains on increasingly 
larger groups of persons in institutions, homes, nurseries, and in cities 
in different parts of the world where large numbers of susceptible chil-
dren and adults were in contact with varying and increasing numbers 
of vaccinated children. Ali of these studies have led to the conclusion, 
that the transmission of polioviruses from vaccinated to unvaccinated is 
not associated with any hazard of acquiring poliomyelitis. 
The studies on the multiplication of the vaccine strains in the hu-
m a n alimentary tract revealed many new facts of basic importance to the 
use of oral vaccines for the control and elimination of poliomyelitis. 
Thus the vaccine strains multiplied extensively in the intestinal tracts 
of those without naturally acquired immunity, regardless of whether or 
not or how much specific antibody they m a y have, either placentally 
transmitted or acquired from inoculations of killed virus vaccine. On 
the other hand in persons with naturally acquired immunity, the vaccine 
strains multiplied poorly or not at ali depending in part on the dose 
fed — again without reference to the levei of demonstrable antibody 
in the blood. Resistance to reinfection after oral vaccine feeding was 
as good or better than after naturally acquired infection. The degree 
of subsequent intestinal resistance to reinfection was found to be inde-
pendent of the presence of demonstrable antibody in the blood, but de-
pended rather on the extent of initial multiplication in the intestinal 
tract, which is optimal when each type multiplies separately as long as 
possible without interference from other viruses. 
Interference by other intestinal viruses became another problem for 
intensive study. Under certain conditions, the multiplication of another 
virus in the intestinal tract was found to interfere either with the ini-
tial inoculation of the vaccine strain or with its multiplication at a high 
levei for a sufficiently long time to produce an adequate antibody res-
ponse or adequate resistance to reinfection. As regards the interference 
among the three different tipes of vaccine virus, the problem was solved 
by administering the three types separately at intervals of not less than 
four to six weeks, or by administering a mixture of the three types on 
two or three occasions. As regards interference by other enteric vi-
ruses, it was found that they played no significant role during the 
winter and spring months in temperate climates in countries like the 
U.S.A., Britain, Switzerland, Czechoslovakia and Yugoslavia, where ni-
nety-five to one hundred per cent of young children developed antibody 
to ali three types following the feeding of the three types separately or 
of the trivalent mixture on three occasions. T n subtropical and tropical 
countries, where the prevalence of naturally occurring polioviruses and 
other enteric viruses has been found to be extraordinarily high among 
young children during ali months of the year, rapid mass feeding of a 
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mixture of ali three types of the vaccine was found to result in a marked 
suppression of the naturally occurring enteric viruses for a period of 
about four weeks and an extensive natural transmission of the vaccine 
strains. This natural transmission of the vaccine strains is, however, 
so markedly curtailed in about 4 to 6 weeks, that it is necessary to 
repeat the mass feeding a second time to achieve immunization of ni-
nety per cent or more of the previously non-immune children. This 
procedure of mass vaccination in tropical countries can thus harmlessly 
achieve within a few months an immunogenic effect in the child popu-
lation for which nature requires at least four years and for which na-
ture extracts a varying and sometimes high price in paralysis. 
The routine use of oral poliovirus vaccine on a mass scale which 
began in many countries in 1960 was precedecl by the most extensive 
trials in different parts of the world over a periocl of three years. In 
1957, 1958 anel 1959 the tests proceeded step by step on increasingly larger 
numbers — tests on hundreds were followed by tests on thousands, ten 
thousands, hundred thousands and finally in the spring of 1959 on mil-
lions. In ali of these preliminary trials fifty per cent or more of the 
population remained unvaccinated to study the effects of the spread of 
the vaccine strains to the unvaccinated. Trials were carried out in 
countries with large numbers of susceptible adults as well as in countries 
where almost ali persons over five years of age are immune. In ali of 
these trials it was evident that the spread of the vaccine strains to 
unvaccinated susceptible children and adults, and the resulting immuni-
zation by contact, was without harmful effects — a fact that has been 
amply confirmed by extensive subsequent experience in many countries. 
The remarkable international collaboration, without reference to political 
orientation of countries, was particularly gratifying because it showed 
how barriers can be overcome when people decide, to work together on a 
common goal of importance to ali mankincl. I particularly wish to men-
tion here the great contribution of the first excellent mass trial on 
144,000 children in Czechoslovakia at the end of 1958 and the subsequent 
excellent studies on millions of children in the Soviet Union in 1959. 
The large numbers of susceptible adults in Estônia, Latvia and Lithuania 
provided data of special importance that were lacking before. The of-
ficial acceptance of the vaccine in the United States in August, 1960, 
followed studies with ali three types in the American cities of Cincinnati, 
Ohio and Rochester, N e w York, on a total of about three hundred thou-
sand children in the spring of 1960, and further large scale tests in 
different cities wrere carried out in 1961 before licensure of the com-
mercially produced vaccines. 
The extensive laboratory tests that were carried out during the 
Cincinnati study in the spring of 1960 showed that vaccination of about 
seventy-five per cent of the pre-school children with ali three types and 
of the school children with type one was capable of breaking the chain 
of transmission not only of type one but of ali three types of poliovirus 
after an initial extensive dissemination of the vaccine strains in the com-
munity. Similar studies in Czechoslovakia and Hungary, where more 
than ninety per cent of the children were vaccinated in 1960, showed 
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a similar suppression of dissemination of polioviruses and with it a sup-
pression of paralytic disease caused by polioviruses. In Rochester, N e w 
York, where as a result of improper organization only twenty per cent 
of the pre-school children received the type one and type three oral 
Vaccines in M a y and June of 1960, there was evidence that the spread 
of naturally pccurring type one poliovirus which was previously present 
in the community was not prevented. In México, where the incidence 
of naturally occurring polioviruses is much higher, the administration of 
oral vaccine to only twenty to fifty per cent of the pre-school children 
during the field trials of 1959 did not significantly alter the dissemina-
tion of polioviruses and the disease continued to occur among the non-
-immune portions of the population the following year. 
Since the first mass use of the oral vaccines in 1960, it is estimated 
that almost two hundred and fifty million people in ali parts of the 
world have received the vaccine both in emergency anti-epidemic pro-
grams as well as in routine immunization programs.. These mass programs 
have not been without problems of interpretation of the significance of 
a great variety of concurrent disease. W h e n hundreds of thousands or 
millions of people are simultaneously given a vaccine or a drink of water 
or anything else, it must be expected that the various diseases which 
afflict human beings will continue to occur in the subsequent days, 
weeks, and months. And yet the tendency for post hoc propter hoc rea-
soning is so great, that almost everything under the sun — both good 
and bad — has been blamed on the vaccine during these mass campaigns. 
The most difficult to answer are those who ask whether you can with 
absolute certainty exclude the possibilita that a certain event or a cer-
tain illness, particularly one that occurs only rarely, is not related to 
the vaccination. It is obvious that diseases which occur without any 
reference to vaccination will have a similar frequency also after vacci-
nation. Controlled studies have been carried out in many places to de-
termine especially wheter the oral vaccines produce fever, systemic simp-
toms, or any sort of illness, and these have invariably shown the same 
frequency among non-contact, unvaccinated persons as among the vacci-
nated. Of particular interest have been diseases that are associated with 
various forms of paralysis that are known to have a variety of causes 
other than the polioviruses — among these one may mention particularly 
infectious polyneuritis and disseminated, perivenous encephalomyelitis. 
Although it should hardly be necessary to stress this point, it must, 
nevertheless, be emphasized that these diseases which occur irregularly 
in different places and different times, without any reference to vacci-
nation, must also be expected to appear among some of the millions of 
persons who receive the oral poliovirus vaccine, or for that matter any-
thing else. During the very careful clinicai and virologic surveillance 
that w e carried out in Cincinnati in 1960 after the administration of 
oral vaccine to about one hundred and eighty thousand children under 
19 years out of a total population of about eight hundred and fifth 
thousand, w e encountered 3 fatal cases of infectious polyneuritis (or 
polyradiculitis as some call it), and it so happened that ali of them 
occurred in persons who did not receive the vaccine, had no intimate 
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association with vaccinated persons, and had no poliovirus in their stools. 
B y mere chance, of course, the opposite coulcl have happened and dicl 
happen in other places. On the basis of ali the accumulated information 
in various countries there is now no justification for regarding various 
neurologic manifestations that are only rarely encountered among per-
sons who have received the oral vaccines as anything but coincidental. 
The experience of the past three years have already given us an 
indication of the requirements for obtaining the best results with the 
oral vaccines, although it is obvious that much remains to be learned 
in the coming years. There is now no cloubt that epidemics of poliomye-
litis can be quickly aborted by the mass use of oral vaccine. To achieve 
the best results it is necessary to start early when only a few cases 
indicate that an epidemic may develop rather than after many cases 
have already appeared and the population is widely seecled with the epi-
demic virus. The optimum results are also obtained when vaccine of 
the same type as that responsible for the outbreak is used. Organization 
for mass administration should and can be rapid, and the vaccine shoulcl 
and can be administered to the maximum possible number of suscepti-
bles within a few days rather than over a period of many weeks. The 
people must be told to expect some cases of the disease among vacci-
nated persons chiefly because they were already infected before recei-
ving the vaccine, but that the vaccine can quickly protect those who had 
not yet been infected. 
But it is better to prevent epidemics than to undertake emergency 
procedures for stopping them after needless cases of paralysis and death 
have occurred. Programs for the elimination not only of epidemics but of 
ali paralytic disease caused by the polioviruses in volve two phases: 
1. Community-wide oral vaccination preferably during the winter 
and spring months of the year of at least seventy-five per cent of the 
most susceptible age groups, regardless of how many doses of killed-virus 
vaccine they may have had with special emphasis on the pre-school chil-
dren, who are the most important disseminators of the polioviruses. The 
purpose of this first phase is not only to immunize those who are not 
immune, but also to create enough resistant intestinal tracts to break 
the chain of transmission of the polioviruses and thereby to protect also> 
those in the family and community who failed to receive the vaccine. 
2. Continuing immunization with oral vaccine of the oncoming ge-
nerations of children during their first year of life as part of their re-
gular medicai care. 
Experience in many different parts of the world has now shown 
that the first phase of such programs can be accomplished with great 
success wherever the public health authorities or the medicai societies 
have provided the leadership for organizing the communities in a con-
certed effort to make the vaccine available within a brief period of time 
to ali people without reference to their ability to pay. The extraordinary 
success that can be achieved in reaching the major part of large popu-
lations on a single Sunday has been amply demonstrated by the remar-
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kable community programs developed by medicai societies in the United 
States in 1962. It is now quite clear that properly performed commu-
nity programs, utilizing ali three types of the vaccine, can within a few 
months achieve a most marked or complete cessation of transmission of 
polioviruses and an elimination of paralytic disease caused by poliovi-
ruses. However, the extent to which systematic on-going programs with 
oral poliovirus vaccines are succesfully put in operation for the new ge-
nerations of children will determine how well poliomyelitis will stay 
eliminated. Where killed virus vaccine, which has practically no effect 
on the dissemination of polioviruses, will be used for one portion of the 
oncoming child population and the oral vaccines for another, or wherever 
improved methods for reaching most of the newborn children during 
their first year of life will not be developed, many children will be 
immunized but complete elimination of poliomyelitis will not be achieved. 
It may be predicted that in communities that have had satisfactory ini-
tial mass immunization programs but have failed to develop adequate 
programs for oral vaccination of most of the children during their first 
year of life, poliomyelitis will within a few years again become a threat 
to the unimmunized and inadequately immunized children and adults. 
In oral poliovirus vaccines we now have remarkable tools for the 
attempted eradication of poliomyelitis within a short time in many parts 
of the world. However, only the optimum utilization of present know-
ledge and continued long-range studies and careful observations under 
different epidemiologic conditions, will teach us what may be needed for 
complete and lasting victory. Therefore, it would be well to remember 
Sir Francis Drake's admonition: "Grant us to know that it is not the 
beginning, but the continuing of the same until it is thoroughly finished, 
which yieldeth the true glory" 
